Worthington Steel, Inc. - WS STOCK NEWS

Vicarious Surgical (NYSE: RBOT, RBOT WS) reported preliminary unaudited financial results for Q4 and the full year 2021. The company experienced a significant increase in operating expenses, totaling $18.2 million in Q4, up 380% year-over-year. Adjusted net loss for Q4 was $18.2 million, or $0.15 per share, compared to a loss of $3.8 million, or $0.04 per share in the prior year. Full year operating expenses reached $38.6 million, reflecting a 197% increase. Cash and cash equivalents stood at $173.5 million as of December 31, 2021.

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announced its participation in two upcoming virtual investor conferences. The Cowen 42nd Annual Healthcare Conference will feature a presentation on Tuesday, March 8, at 9:10 a.m. ET. Additionally, the Oppenheimer 32nd Annual Healthcare Conference is scheduled for Wednesday, March 16, at 8:40 a.m. ET. Interested parties can access live and archived presentations on the company's website. Vicarious Surgical is focused on innovative robotics technology aimed at improving surgical efficiency and patient outcomes.

Alvotech and Fuji Pharma have expanded their strategic partnership to include six biosimilar products aimed at the Japanese market. The agreement grants Fuji exclusive commercial rights to an undisclosed biosimilar in early development, with Alvotech receiving upfront and milestone payments, along with a share of sales. This strengthens Alvotech's position in Japan, the third largest pharmaceutical market globally. The collaboration emphasizes both companies' commitment to enhancing patient access to biosimilars, ultimately contributing to healthcare sustainability.

Vicarious Surgical Inc. (NYSE: RBOT) will release its fourth quarter 2021 financial results on March 3, 2022, after market close. A conference call, starting at 4:30 p.m. ET, will follow to discuss the results. Investors can participate by calling 1 (646) 904 5544 domestically or +1 (929) 526 1599 internationally. Vicarious Surgical, founded in 2014, focuses on enhancing surgical efficiency and reducing healthcare costs using proprietary robotic technology.

Energy Vault (NRGV, NRGV WS) commenced trading on February 14, 2022, following its business combination with Novus Capital Corporation II. The transaction secured approximately $235 million in gross proceeds, supplementing a $107 million Series C funding and a $50 million licensing fee from Atlas Renewable. This capital will support Energy Vault's growth strategy in sustainable, grid-scale energy storage technologies aimed at decarbonization. CEO Robert Piconi emphasized the strategic partnerships enhancing shareholder value.

Novus Capital Corporation II (NYSE: NXU, NXUU, WS) has received stockholder approval for its business combination with Energy Vault, Inc. at a special meeting held on February 10, 2022. The transaction is expected to close on February 11, 2022, and the new entity will be named Energy Vault Holdings, Inc., with trading commencing on February 14, 2022 under ticker symbols 'NRGV' and 'NRGV WS'. Energy Vault specializes in sustainable energy storage technologies aimed at reducing energy costs for utilities and large industrial users.

Energy Vault will host a fireside chat with IPO Edge on February 8, 2022, at 2pm ET to discuss its business combination with Novus Capital Corporation II (NYSE: NXU). The chat will cover Energy Vault's gravity-based energy storage technology and recent partnerships with DG Fuels LLC, BHP, and others. The Special Meeting to approve the merger is set for February 10, 2022, at 10:00 a.m. ET. If approved, trading under new ticker symbols 'NRGV' and 'NRGV WS' will commence shortly thereafter.

Novus Capital Corporation II (NYSE: NXU, NXU WS, NXU.U) urges stockholders to vote for the proposed business combination with Energy Vault, Inc. The Special Meeting is scheduled for February 10, 2022, at 10:00 a.m. ET, where stockholders can approve the merger. Should the deal go through, trading of the combined entity's shares will commence under the new ticker symbols 'NRGV' and 'NRGV WS' on the NYSE. Stockholders are encouraged to submit their proxy votes by 11:59 p.m. ET on February 9, 2022.

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) will engage in a fireside chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16 at 4:00 p.m. Eastern Time. The company focuses on enhancing surgical procedures through next-generation robotic technology, which has been recognized by the FDA with a Breakthrough Device Designation. Founded in 2014, Vicarious Surgical aims to improve patient outcomes while reducing healthcare costs. The event is accessible via BTIG representatives.